← Leaderboards
Stacy Alyse Malaker
Stanford University
$1,968,349
Attributed
$2,192,536
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $867.1K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,192,536 · 3
By mechanism
R35$1,619,389 · 1
R21$448,375 · 1
F32$124,772 · 1
Top collaborators
- Barbara Anne Bensing1 shared
Most similar at Stanford University
Same institution · by research overlap
- James D Brooks$12,828,912
- Sharon Pitteri$2,838,162
- Melanie Hayden Gephart$6,763,817
- Calvin J Kuo$48,363,495
- Christina N Curtis$16,294,717
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsMucinsModificationStructurePolysaccharidesProteinsGlycosylationGlycoproteinsBindingMass Spectrum AnalysisBiologicalImmunoglobulinsMucinasePeptide HydrolasesCancer ImmunotherapyMembrane GlycoproteinsLigandsExperimental StudyMalignant - DescriptorEnzymesInsightLaboratoriesTumorTumor Progression
Grant awards (7)
PRG4/Lubricin glycoform variants associated with endocardial infections and sepsis$448,375
R21 · FY2025 · AI
Toward understanding the role of altered glycosylation in cancer$418,750
R35 · FY2025 · GM · contact PI
Toward understanding the role of altered glycosylation in cancer$418,750
R35 · FY2024 · GM · contact PI
Toward understanding the role of altered glycosylation in cancer$418,750
R35 · FY2023 · GM · contact PI
Toward understanding the role of altered glycosylation in cancer$363,139
R35 · FY2022 · GM · contact PI
An enzymatic approach to study cancer-associated cell-surface glycoproteins: exploration of mucin-degrading bacterial metalloproteases$65,606
F32 · FY2019 · GM · contact PI
An enzymatic approach to study cancer-associated cell-surface glycoproteins: exploration of mucin-degrading bacterial metalloproteases$59,166
F32 · FY2017 · GM · contact PI